BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4375534)

  • 1. The effects of anticholinesterases on synaptic transmission through nicotinic and muscarinic receptors in rat sympathetic ganglia in vivo.
    Drew GM; Leach GD
    Br J Pharmacol; 1974 Sep; 52(1):51-9. PubMed ID: 4375534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actions of anticholinesterase agents upon ganglionic transmission in the dog.
    Gillis RA; Flacke W; Garfield JM; Alper MH
    J Pharmacol Exp Ther; 1968 Oct; 163(2):277-86. PubMed ID: 4300677
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of muscarinic ganglionic stimulation and blockade upon ganglion responses to DMPP and nicotine.
    Graça AS; Hilton JG; Silva AJ
    Arch Int Pharmacodyn Ther; 1970 Aug; 186(2):379-87. PubMed ID: 4331696
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of hydralazine on canine muscarinic ganglion stimulation.
    Gomer SK; Hilton JG
    Eur J Pharmacol; 1978 Mar; 48(2):143-50. PubMed ID: 76567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of arecoline on transmission through the superior cervical ganglion of the cat.
    Krstić MK
    Arch Int Pharmacodyn Ther; 1971 Dec; 194(2):253-8. PubMed ID: 4331176
    [No Abstract]   [Full Text] [Related]  

  • 6. Selective activation of nicotinic and muscarinic transmission in cardiac sympathetic ganglion of the dog.
    Chinn C; Hilton JG
    Eur J Pharmacol; 1976 Nov; 40(1):77-82. PubMed ID: 186279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. THE EFFECTS OF NEOSTIGMINE UPON GANGLION RESPONSES AFTER ADMINISTRATION OF BLOCKING DRUGS.
    FENNER PA; HILTON JG
    Br J Pharmacol Chemother; 1963 Oct; 21(2):323-30. PubMed ID: 14081662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric interaction of the anticholinergic drug [N-(4-phenyl)-phenacyl-l-hyoscyamine] (Phenthonium) with nicotinic receptors of post-ganglionic sympathetic neurons of the rat vas deferens.
    Munhoz E; De Lima TC; Souccar C; Lapa AJ; Lima-Landman MT
    Eur J Pharmacol; 2009 Aug; 616(1-3):229-35. PubMed ID: 19540221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of ganglionic muscarinic activity by gallamine.
    Gardier RW; Ganansia MF; Delaunois AL; Hamelberg W
    Anesthesiology; 1974 May; 40(5):494-7. PubMed ID: 4150775
    [No Abstract]   [Full Text] [Related]  

  • 10. The autonomic pharmacology of the bladder.
    Taira N
    Annu Rev Pharmacol; 1972; 12():197-208. PubMed ID: 4339016
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the specificity of the inhibitory action of N,N-diisopropyl-N'-isoamyl-N'-diethylaminoethylurea (P-286) on adrenal catecholamine release in the anaesthetized rat.
    Malta E; Angus JA
    Clin Exp Pharmacol Physiol; 1988 Nov; 15(11):815-25. PubMed ID: 3229006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A ganglionic stimulant, 1,1-dimethyl-4-phenylpiperazinium, caused both cholinergic and adrenergic responses in the isolated mouse atrium.
    Ochi K; Teraoka H; Unno T; Komori S; Yamada M; Kitazawa T
    Eur J Pharmacol; 2013 Mar; 704(1-3):7-14. PubMed ID: 23461847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurophysiology and pharmacology of long-term potentiation in the rat sympathetic ganglion.
    Briggs CA; Brown TH; McAfee DA
    J Physiol; 1985 Feb; 359():503-21. PubMed ID: 2860242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contraction of the urinary bladder by muscarinic ganglionic stimulants: possible existence of muscarinic receptor sites on its parasympathetic ganglia.
    Saxena PR
    Arch Int Pharmacodyn Ther; 1972 Sep; 199(1):16-28. PubMed ID: 4403681
    [No Abstract]   [Full Text] [Related]  

  • 15. Nicotinic and muscarinic receptors in the cardiac sympathetic ganglia of the dog.
    Fleisch JH; Flacke W; Gillis RA
    J Pharmacol Exp Ther; 1969 Jul; 168(1):106-15. PubMed ID: 4307315
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of methoxyflurane on sympathetic ganglionic transmission.
    Pilon RN; Alper MH; Flacke W
    Anesthesiology; 1973 Sep; 39(3):302-7. PubMed ID: 4353903
    [No Abstract]   [Full Text] [Related]  

  • 17. The pharmacology of the nicotinic antagonist, chlorisondamine, investigated in rat brain and autonomic ganglion.
    Clarke PB; Chaudieu I; el-Bizri H; Boksa P; Quik M; Esplin BA; Capek R
    Br J Pharmacol; 1994 Feb; 111(2):397-405. PubMed ID: 7911713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of deslanoside-induced cardiotoxicity by combined nicotinic and muscarinic blockade of autonomic ganglia.
    Gillis RA; Jolson H; Thibodeaux H; Levitt B
    J Pharmacol Exp Ther; 1975 Oct; 195(1):126-32. PubMed ID: 241837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Afterdischarge on postganglionic sympathetic nerves following repetitive stimulation of the preganglionic nerve to the rat superior cervical ganglion in vitro.
    McIsaac RJ
    J Pharmacol Exp Ther; 1977 Jan; 200(1):107-16. PubMed ID: 833752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular control by cholinergic mechanisms in the rostral ventrolateral medulla.
    Willette RN; Punnen S; Krieger AJ; Sapru HN
    J Pharmacol Exp Ther; 1984 Nov; 231(2):457-63. PubMed ID: 6149311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.